S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
S&P 500   3,168.57 (+0.86%)
DOW   28,132.05 (+0.79%)
QQQ   206.51 (+0.75%)
AAPL   271.46 (+0.25%)
FB   196.75 (-2.72%)
MSFT   153.24 (+1.02%)
GOOGL   1,348.49 (+0.32%)
AMZN   1,760.33 (+0.66%)
CGC   21.13 (+4.35%)
NVDA   224.32 (+3.21%)
MU   50.97 (+3.47%)
BABA   204.50 (-0.07%)
GE   11.44 (+4.28%)
TSLA   359.68 (+1.98%)
T   38.35 (+0.47%)
AMD   42.59 (+7.90%)
ACB   2.60 (+6.12%)
F   9.32 (+2.31%)
PRI   136.50 (+0.78%)
NFLX   298.50 (-0.14%)
BAC   34.68 (+3.09%)
GILD   67.63 (-0.22%)
DIS   147.76 (+0.12%)
Log in

Cue Biopharma News Headlines (NASDAQ:CUE)

$12.40
-0.31 (-2.44 %)
(As of 12/12/2019 04:00 PM ET)
Today's Range
$12.29
Now: $12.40
$12.99
50-Day Range
$7.96
MA: $9.93
$12.73
52-Week Range
$4.16
Now: $12.40
$13.20
Volume89,842 shs
Average Volume97,150 shs
Market Capitalization$285.13 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Headlines

Cue Biopharma (NASDAQ CUE) News Headlines

Source:
DateHeadline
Heres Why Cue Biopharma, Inc. (CUE) is a Great Momentum Stock to BuyHere's Why Cue Biopharma, Inc. (CUE) is a Great Momentum Stock to Buy
www.nasdaq.com - December 6 at 1:07 PM
Here's Why Cue Biopharma, Inc. (CUE) is a Great Momentum Stock to BuyHere's Why Cue Biopharma, Inc. (CUE) is a Great Momentum Stock to Buy
finance.yahoo.com - December 6 at 1:07 PM
Cue Biopharma to Present at the World Vaccine & Immunotherapy CongressCue Biopharma to Present at the World Vaccine & Immunotherapy Congress
finance.yahoo.com - December 2 at 12:55 PM
Cue Biopharma, Inc. (CUE) Shares March Higher, Can It Continue?Cue Biopharma, Inc. (CUE) Shares March Higher, Can It Continue?
finance.yahoo.com - December 2 at 12:55 PM
Zacks: Analysts Expect Cue Biopharma Inc (NASDAQ:CUE) Will Post Earnings of -$0.51 Per ShareZacks: Analysts Expect Cue Biopharma Inc (NASDAQ:CUE) Will Post Earnings of -$0.51 Per Share
www.americanbankingnews.com - November 20 at 3:28 PM
What Makes Cue Biopharma, Inc. (CUE) a New Strong Buy StockWhat Makes Cue Biopharma, Inc. (CUE) a New Strong Buy Stock
finance.yahoo.com - November 15 at 9:41 AM
Cue Biopharma EPS beats by $0.13Cue Biopharma EPS beats by $0.13
seekingalpha.com - November 12 at 7:37 PM
Cue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business HighlightsCue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - November 12 at 7:37 PM
Cue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business HighlightsCue Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights
finance.yahoo.com - November 12 at 7:37 PM
Cue Biopharma to Present at Upcoming Investor Conferences in November 2019Cue Biopharma to Present at Upcoming Investor Conferences in November 2019
finance.yahoo.com - November 6 at 12:54 PM
Heres Why Were Watching Cue Biopharmas (NASDAQ:CUE) Cash Burn SituationHere's Why We're Watching Cue Biopharma's (NASDAQ:CUE) Cash Burn Situation
finance.yahoo.com - November 4 at 12:17 PM
Here's Why We're Watching Cue Biopharma's (NASDAQ:CUE) Cash Burn SituationHere's Why We're Watching Cue Biopharma's (NASDAQ:CUE) Cash Burn Situation
finance.yahoo.com - November 3 at 9:31 AM
Cue Biopharma Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual MeetingCue Biopharma Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting
finance.yahoo.com - October 30 at 8:18 AM
Cue Biopharma to Present at the Oppenheimer Houston Oncology Summit at the University of Texas MD Anderson Cancer CenterCue Biopharma to Present at the Oppenheimer Houston Oncology Summit at the University of Texas MD Anderson Cancer Center
finance.yahoo.com - October 15 at 12:21 PM
Cue Biopharma Announces Changes to its Board of DirectorsCue Biopharma Announces Changes to its Board of Directors
finance.yahoo.com - October 9 at 6:21 PM
Cue Biopharma to Present at Upcoming October 2019 Scientific ConferencesCue Biopharma to Present at Upcoming October 2019 Scientific Conferences
finance.yahoo.com - October 9 at 8:20 AM
Cue Biopharma Promotes Dr. Anish Suri to President and CSOCue Biopharma Promotes Dr. Anish Suri to President and CSO
www.marketwatch.com - October 7 at 6:29 PM
Cue Biopharma Promotes Dr. Anish Suri to President and CSOCue Biopharma Promotes Dr. Anish Suri to President and CSO
finance.yahoo.com - October 7 at 6:29 PM
Cue Biopharma to Present Corporate Overview and Update on Clinical Development Progress for CUE-101 at the Cantor 2019 Global Healthcare ConferenceCue Biopharma to Present Corporate Overview and Update on Clinical Development Progress for CUE-101 at the Cantor 2019 Global Healthcare Conference
finance.yahoo.com - October 2 at 4:21 PM
Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 for HPV16-driven Head and Neck Squamous Cell CarcinomaCue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 for HPV16-driven Head and Neck Squamous Cell Carcinoma
finance.yahoo.com - September 30 at 4:34 PM
Read This Before Selling Cue Biopharma, Inc. (NASDAQ:CUE) SharesRead This Before Selling Cue Biopharma, Inc. (NASDAQ:CUE) Shares
finance.yahoo.com - September 21 at 6:36 AM
Do Insiders Own Shares In Cue Biopharma, Inc. (NASDAQ:CUE)?Do Insiders Own Shares In Cue Biopharma, Inc. (NASDAQ:CUE)?
finance.yahoo.com - July 12 at 4:03 PM
Cue Biopharma to Present Corporate Overview & Clinical Strategy for CUE-101 at Jefferies 2019 Healthcare ConferenceCue Biopharma to Present Corporate Overview & Clinical Strategy for CUE-101 at Jefferies 2019 Healthcare Conference
finance.yahoo.com - June 3 at 11:10 AM
FDA accepts Cue Bios IND for CUE-101; shares up 5% premarketFDA accepts Cue Bio's IND for CUE-101; shares up 5% premarket
seekingalpha.com - May 16 at 4:15 PM
Dr. Anish Suri, Cue Biopharma’s CSO, to Participate in Panel Discussion at Upcoming NYAS Frontiers in Cancer Immunotherapy ConferenceDr. Anish Suri, Cue Biopharma’s CSO, to Participate in Panel Discussion at Upcoming NYAS Frontiers in Cancer Immunotherapy Conference
finance.yahoo.com - May 9 at 11:32 AM
If You Had Bought Cue Biopharma (NASDAQ:CUE) Stock A Year Ago, You'd Be Sitting On A 25% Loss, TodayIf You Had Bought Cue Biopharma (NASDAQ:CUE) Stock A Year Ago, You'd Be Sitting On A 25% Loss, Today
finance.yahoo.com - April 29 at 11:14 AM
Cue Biopharma, Inc. Estimate MomentumCue Biopharma, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 4:26 PM
Cue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare ConferenceCue Biopharma to Present Corporate Overview and Update at the Oppenheimer 29th Annual Healthcare Conference
finance.yahoo.com - March 14 at 12:05 PM
Cue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor ConferenceCue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor Conference
www.nasdaq.com - February 12 at 11:47 AM
Cue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor ConferenceCue Biopharma to Present Corporate Update at 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 12 at 11:47 AM
Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Increased Their HoldingsCue Biopharma, Inc. (NASDAQ:CUE) Insiders Increased Their Holdings
finance.yahoo.com - January 31 at 11:01 AM
Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia ConferenceCue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference
finance.yahoo.com - January 16 at 11:03 AM
This Day That Year: Cue Biopharma This Day That Year: Cue Biopharma
www.rttnews.com - January 2 at 2:43 AM
Cue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT™ Target in OncologyCue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT™ Target in Oncology
finance.yahoo.com - December 20 at 10:53 AM
Cue Biopharma, Gravitating Near Concerning Market ParticipantsCue Biopharma, Gravitating Near Concerning Market Participants
seekingalpha.com - December 17 at 3:40 PM
Cue Biopharma, Inc. (CUE) CEO Dan Passeri on Q3 2018 Results - Earnings Call TranscriptCue Biopharma, Inc. (CUE) CEO Dan Passeri on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 10:26 AM
Week In Review: CStone Pharma, A Suzhou Oncology Company, Files For Hong Kong IPOWeek In Review: CStone Pharma, A Suzhou Oncology Company, Files For Hong Kong IPO
seekingalpha.com - November 18 at 3:39 PM
Cue Biopharma to Host Business Update Call and WebcastCue Biopharma to Host Business Update Call and Webcast
finance.yahoo.com - November 14 at 10:13 AM
Cue Biopharma Inc. (CUE) Presents Foundational Data on Immuno-STAT Platform and CUE-101 at SITCCue Biopharma Inc. (CUE) Presents Foundational Data on Immuno-STAT Platform and CUE-101 at SITC
www.streetinsider.com - November 9 at 10:57 AM
Cue Biopharma Presents Foundational Data on Immuno-STAT Platform and CUE-101 at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual MeetingCue Biopharma Presents Foundational Data on Immuno-STAT Platform and CUE-101 at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
finance.yahoo.com - November 9 at 10:57 AM
BRIEF-Cue Biopharma announces strategic collaboration with Lg Chem Life Sciences for Immuno-Stat biologics in oncologyBRIEF-Cue Biopharma announces strategic collaboration with Lg Chem Life Sciences for Immuno-Stat biologics in oncology
www.msn.com - November 8 at 10:43 AM
Cue Bio up 7% premarket on LG Chem partnershipCue Bio up 7% premarket on LG Chem partnership
seekingalpha.com - November 8 at 10:43 AM
Cue Biopharma Announces Strategic Collaboration with LG Chem Life Sciences for Immuno-STAT™ Biologics in OncologyCue Biopharma Announces Strategic Collaboration with LG Chem Life Sciences for Immuno-STAT™ Biologics in Oncology
finance.yahoo.com - November 8 at 10:43 AM
Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual MeetingCue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
finance.yahoo.com - October 30 at 10:33 AM
Cue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of Immuno-STAT™ Platform in Chronic Infectious DiseasesCue Biopharma Announces Strategic Research Collaboration with Albert Einstein College of Medicine to Further the Potential of Immuno-STAT™ Platform in Chronic Infectious Diseases
finance.yahoo.com - October 17 at 10:15 AM
What Kind Of Shareholders Own Cue Biopharma Inc (NASDAQ:CUE)?What Kind Of Shareholders Own Cue Biopharma Inc (NASDAQ:CUE)?
finance.yahoo.com - October 16 at 3:29 PM
Form 4 Cue Biopharma, Inc. For: Aug 29 Filed by: Millar Kerri-AnnForm 4 Cue Biopharma, Inc. For: Aug 29 Filed by: Millar Kerri-Ann
www.streetinsider.com - August 30 at 10:45 AM
Cue Biopharma, Inc. (CUE) CEO Dan Passeri Hosts Investor Business Update Call (Transcript)Cue Biopharma, Inc. (CUE) CEO Dan Passeri Hosts Investor Business Update Call (Transcript)
seekingalpha.com - August 28 at 10:30 AM
Cue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of DirectorsCue Biopharma Adds Frank Morich, M.D., Ph.D. to Board of Directors
finance.yahoo.com - August 3 at 11:41 AM
Cue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice PresidentCue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice President
finance.yahoo.com - July 24 at 10:35 AM
This page was last updated on 12/12/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel